Oncology - Pharmacology/Therapy News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Smartest Doc Challenge
MDLinx
Today Only! We’re helping you prep for your board exams

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (10) Full Text Articles (1643) Focus on Pancreas

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

201 Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases Supportive Care in Cancer, May 6, 2013 Clinical Article

202 The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy Supportive Care in Cancer, May 6, 2013 Clinical Article

203 Cediranib for Metastatic Alveolar Soft Part Sarcoma Journal of Clinical Oncology, May 6, 2013 Clinical Article

204 New treatment options for castration-resistant prostate cancer American Journal of Health-System Pharmacy, May 6, 2013 Clinical Article

205 Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China Leukemia Research, May 6, 2013 Clinical Article

206 The Correlation Between Dose of Folinic Acid and Neurotoxicity in Children and Adolescents Treated for Osteosarcoma With High-dose Methotrexate (HDMTX): A Neuropsychological and Psychosocial Study Journal of Pediatric Hematology/Oncology, May 6, 2013 Clinical Article

207 A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy Molecular Cancer Therapeutics, May 6, 2013 Clinical Article

208 Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors Clinical Cancer Research, May 3, 2013 Clinical Article

209 212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint British Journal of Cancer, May 3, 2013 Clinical Article

210 Disrupting Protein NEDDylation with MLN4924 is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer Clinical Cancer Research, May 3, 2013 Clinical Article

211 Temozolomide-Mediated DNA Methylation in Human Myeloid Precursor Cells: Differential Involvement of Intrinsic and Extrinsic Apoptotic Pathways Clinical Cancer Research, May 3, 2013 Clinical Article

212 Concomitant BRAF and PI3K/mTOR Blockade Is Required for Effective Treatment of BRAFV600E Colorectal Cancer Clinical Cancer Research, May 3, 2013 Clinical Article

213 Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia Journal of Clinical Oncology, May 3, 2013 Clinical Article

214 Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK British Journal of Cancer, May 3, 2013 Clinical Article

215 Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer Cancer, May 3, 2013 Clinical Article

216 Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma Cancer Research, May 3, 2013 Clinical Article

217 Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors Cancer Chemotherapy and Pharmacology, May 3, 2013 Clinical Article

218 MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination Cancer Chemotherapy and Pharmacology, May 3, 2013 Clinical Article

219 A Systematic Review of Complementary and Alternative Medicine Interventions for the Management of Cancer-Related Fatigue Integrative Cancer Therapies , May 3, 2013 Review Article Clinical Article

220 The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer Gynecologic Oncology, May 3, 2013 Clinical Article

50 available pages First Previous 11 12 13 14 15 16 17 18 19 20 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Enalapril And Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients with Malignant Hemopathies. The OVERCOME Trial JACC - Journal of the American College of Cardiology, April 12, 2013

2 Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia Annals of Hematology, April 9, 2013

3 A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases Clinical Cancer Research, April 5, 2013

4 Controversies of the Hormonal Conservative Treatment of Endometrial Cancer Gynecologic and Obstetric Investigation, April 12, 2013 Review Article

5 The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia Hematology, March 14, 2013

6 Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer Lung Cancer, April 3, 2013

7 Successful treatment by azacitidine therapy of intestinal Behçets disease associated with myelodysplastic syndrome International Journal of Hematology, April 2, 2013

8 Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China Cancer, April 12, 2013

9 Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02 Journal of Clinical Oncology, April 11, 2013

10 Mammographic Breast Density Response to Aromatase Inhibition Clinical Cancer Research, March 13, 2013

11 A review of iniparib in ovarian cancer Expert Opinion on Investigational Drugs, March 14, 2013

12 Continuous treatment with new agents for newly diagnosed multiple myeloma Anti-Cancer Drugs, April 9, 2013 Evidence Based Medicine Review Article

13 Analysis of Treatment Outcomes of Intraventricular Chemotherapy in 105 Patients for Leptomeningeal Carcinomatosis from Non-Small-Cell Lung Cancer Journal of Thoracic Oncology, April 18, 2013

14 Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis Breast Cancer Research and Treatment, April 18, 2013

15 Clinical Analysis of Gefitinib in the Treatment of Stage IV Lung Adenocarcinoma with Unknown EGFR Gene Mutations Thoracic Cancer, April 5, 2013

16 Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer Journal of Clinical Oncology, April 11, 2013

17 Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer Annals of Thoracic Medicine, April 2, 2013 Free full text

18 Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study Lung Cancer, April 1, 2013

19 The changing paradigm of CLL management European Journal of Internal Medicine , April 17, 2013 Review Article

20 90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial Journal of Clinical Oncology, April 4, 2013

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Oncology - Pharmacology/Therapy News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology